like us on facebook connect with us on linkedin follow us on twitter November 30, 2022

Key Changes for 2023

To learn more about or register for this webinarCLICK HERE.

Section Header Section Header Section Header

MSHO Featured Corporate Sponsor Assistance Programs

• AVEO ACE
• KaryForward®: Patient Support by Karyopharm
• Novartis Patient Assistance Foundation

Details >
Section Header

WPS Oncology Related LCD Updates

November 2022

Stay current on retired and revised policies/articles

Details >

WPS Recent Oncology Related News

Part A, Part B and Part A/B News

• WPS Closures
• Part B Immunosuppressant Drug (Part B-ID) Data in WPS Portal & IVR
• Medicare Hot Links to 2022 Final Rules and the WPS Fee Schedules

Details >
Section Header

CMS-Medicare

Recent Oncology Related Articles

• Dec 2 deadline to Submit a Payment Adjustment Reconsideration
• MIPS SAFER Guide Requirements
• Improper Payments
• Recent Learn Resource & MedLearn Matters Articles
• And more

Details >

Recent RAC Monitor Article

This edition includes articles on

• Understanding the Bottom Line in Healthcare
• Key Words to Look for in Federal Regulations Governing Healthcare Payment

Details >
Section Header

BCBSM/BCN

Recent Oncology Related News

• Guidelines for Billing Genetic Testing 
• New & Updated Questionnaires in the E-Referral System
• Blue Cross programs target lower costs and medication adherence
• Billing chart
• And more

Details >

BCBSM/BCN

Publications

• The Record
• BCN Provider News

Details >
Section Header

Current Payer Issue Tracking Page

Last Reviewed/Updated 11/30/22

• 10/11 Update on BCBSM Denials for Auth Exceeds Allowed

Details >

Resolved Payer Issues

Last Reviewed/Updated 11/30/22

• BCBSM Phesgo Issue and Denials for Auth Exceeds Allowed

Details >

Medicaid

Recent Oncology Related News

Medicaid Updates Include
• MSA Bulletin Updates
• Biller "B" Aware Notices

Details >

Newsletters of Interest

• Aetna OfficeLink Updates
• Cigna
• HAP
• Humana YourPractice
• UHC Network News

Details >

Priority Health Update

• 2023 Commercial Fee Schedules
• Commercial HMO, EPO, POS, and PPO Plan Fee Schedules
• Medicare Fee Schedules
• Medicaid and Healthy Michigan Plan fee schedules
• Medicaid capitation methodology

Details >
Section Header

Recent Oncology Related FDA Approvals and Expanded Indications

• SeaGen Adcetris® (brentuximab vedotin)
• AstraZeneca Imfinzi and Imjudo with chemotherapy

Details >

Drug Updates

• Jazz Pharmaceutical Intramuscular Dosing Schedule for Rylaze® (asparaginase erwinia chrysanthemi (recombinant)-rywn)

Details >
Section Header Section Header